- Home
- MRSN vs AIXI Comparison
MRSN vs AIXI Comparison
Compare MRSN & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- AIXI
- Stock Information
- Founded
- MRSN 2001
- AIXI 2001
- Country
- MRSN United States
- AIXI China
- Employees
- MRSN N/A
- AIXI N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- AIXI Computer Software: Prepackaged Software
- Sector
- MRSN Health Care
- AIXI Technology
- Exchange
- MRSN Nasdaq
- AIXI Nasdaq
- Market Cap
- MRSN 37.0M
- AIXI 31.2M
- IPO Year
- MRSN 2017
- AIXI 2023
- Fundamental
- Price
- MRSN $7.66
- AIXI $1.59
- Analyst Decision
- MRSN Strong Buy
- AIXI
- Analyst Count
- MRSN 3
- AIXI 0
- Target Price
- MRSN $33.00
- AIXI N/A
- AVG Volume (30 Days)
- MRSN 90.2K
- AIXI 198.5K
- Earning Date
- MRSN 08-13-2025
- AIXI 10-27-2025
- Dividend Yield
- MRSN N/A
- AIXI N/A
- EPS Growth
- MRSN N/A
- AIXI N/A
- EPS
- MRSN N/A
- AIXI N/A
- Revenue
- MRSN $34,769,000.00
- AIXI $70,314,315.00
- Revenue This Year
- MRSN N/A
- AIXI $26.84
- Revenue Next Year
- MRSN N/A
- AIXI N/A
- P/E Ratio
- MRSN N/A
- AIXI N/A
- Revenue Growth
- MRSN 16.14
- AIXI 18.84
- 52 Week Low
- MRSN $5.21
- AIXI $1.29
- 52 Week High
- MRSN $70.75
- AIXI $8.31
- Technical
- Relative Strength Index (RSI)
- MRSN 54.20
- AIXI 48.36
- Support Level
- MRSN $6.63
- AIXI $1.29
- Resistance Level
- MRSN $7.25
- AIXI $1.92
- Average True Range (ATR)
- MRSN 0.52
- AIXI 0.17
- MACD
- MRSN 0.02
- AIXI 0.02
- Stochastic Oscillator
- MRSN 65.86
- AIXI 48.18
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.